Literature DB >> 10772080

Fas and perforin contribute to the pathogenesis of murine cerebral malaria.

S Potter1, G Chaudhri, A Hansen, N H Hunt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10772080     DOI： 10.1179/135100099101535070

Source DB:  PubMed          Journal:  Redox Rep        ISSN： 1351-0002            Impact factor:   4.412


× No keyword cloud information.
  9 in total

1.  Early cytokine production is associated with protection from murine cerebral malaria.

Authors:  Andrew J Mitchell; Anna M Hansen; Leia Hee; Helen J Ball; Sarah M Potter; John C Walker; Nicholas H Hunt
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 2.  Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei.

Authors:  Sabrina Torre; David Langlais; Philippe Gros
Journal:  Mamm Genome       Date:  2018-06-19       Impact factor: 2.957

Review 3.  Microbial induction of vascular pathology in the CNS.

Authors:  Silvia S Kang; Dorian B McGavern
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-18       Impact factor: 4.147

4.  Expression microarray analysis implicates apoptosis and interferon-responsive mechanisms in susceptibility to experimental cerebral malaria.

Authors:  Fiona E Lovegrove; Sina A Gharib; Samir N Patel; Cheryl A Hawkes; Kevin C Kain; W Conrad Liles
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

5.  Blood-stage Plasmodium infection induces CD8+ T lymphocytes to parasite-expressed antigens, largely regulated by CD8alpha+ dendritic cells.

Authors:  Rachel J Lundie; Tania F de Koning-Ward; Gayle M Davey; Catherine Q Nie; Diana S Hansen; Lei Shong Lau; Justine D Mintern; Gabrielle T Belz; Louis Schofield; Francis R Carbone; Jose A Villadangos; Brendan S Crabb; William R Heath
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-17       Impact factor: 11.205

6.  Artemisone effective against murine cerebral malaria.

Authors:  Judith H Waknine-Grinberg; Nicholas Hunt; Annael Bentura-Marciano; James A McQuillan; Ho-Wai Chan; Wing-Chi Chan; Yechezkel Barenholz; Richard K Haynes; Jacob Golenser
Journal:  Malar J       Date:  2010-08-09       Impact factor: 2.979

7.  Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria.

Authors:  Nana O Wilson; Wesley Solomon; Leonard Anderson; John Patrickson; Sidney Pitts; Vincent Bond; Mingli Liu; Jonathan K Stiles
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

8.  Real-time imaging reveals the dynamics of leukocyte behaviour during experimental cerebral malaria pathogenesis.

Authors:  Saparna Pai; Jim Qin; Lois Cavanagh; Andrew Mitchell; Fatima El-Assaad; Rohit Jain; Valery Combes; Nicholas H Hunt; Georges E R Grau; Wolfgang Weninger
Journal:  PLoS Pathog       Date:  2014-07-17       Impact factor: 6.823

Review 9.  Cerebral malaria: gamma-interferon redux.

Authors:  Nicholas H Hunt; Helen J Ball; Anna M Hansen; Loke T Khaw; Jintao Guo; Supun Bakmiwewa; Andrew J Mitchell; Valéry Combes; Georges E R Grau
Journal:  Front Cell Infect Microbiol       Date:  2014-08-15       Impact factor: 5.293
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.